NCT04856436View on ClinicalTrials.gov

Maternal and Neonatal Outcomes Following Exposure to Benzodiazepines During Pregnancy

CompletedOBSERVATIONAL
Enrollment

3,094,227

Participants

Timeline

Start Date

December 1, 2020

Primary Completion Date

June 30, 2021

Study Completion Date

July 30, 2021

Conditions
Pregnancy RelatedBenzodiazepines Causing Adverse Effects in Therapeutic UseCongenital Anomaly
Interventions
DRUG

Benzodiazepine

Exposure to benzodiazepine during early pregnancy

Trial Locations (1)

16419

Sungkyunkwan University, Suwon

All Listed Sponsors
collaborator

National Research Foundation of Korea

OTHER

lead

Sungkyunkwan University

OTHER

NCT04856436 - Maternal and Neonatal Outcomes Following Exposure to Benzodiazepines During Pregnancy | Biotech Hunter | Biotech Hunter